Chronix Biomedical, Inc.

Detecting and treating cancer before it invades or metastasizes is the best way to ensure the patient survives the disease. Yet, cancers can be asymptomatic for so long that early detection can be dif

Although the scientific sessions at the 2017 American Society of Clinical Oncology annual meeting were dominated by basic research and drug trials, the meeting also featured many presentations on nove

The ability to diagnose a tumor and monitor its progression and response to treatment without the need to obtain a tissue biopsy has been a long-standing goal of cancer management. This capability is

Chronix Biomedical Inc. will start offering around a month from now its circulating cell-free tumour DNA-based test to monitor patients undergoing immunotherapy, following positive results from a st